Transcatheter Closure of Moderate-to-Large Patent Ductus Arteriosus in Infants Using Amplatzer Duct Occluder

Wang, Jou‐Kou; Wu, Mei‐Hwan; Lin, Min; Chiu, Shuenn–Nan; Chen, Chun-An; Chiu, H. H.

doi:10.1253/circj.cj-09-0473

Cited by 40 publications

(28 citation statements)

References 30 publications

(77 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This historic difference in AE rates may be explained by the use of PDA devices for larger PDAs, prompting less embolization of coils through a large ductus, improved coil and catheter technology available for coil implantation, including detachable coils, and the continuous efforts of investigators to improve the efficacy and safety of coil or device placement. The AE rate of our registry (C3PO) is similar to the complication rate reported in more recent studies 4,11–13 (Table 6). …”

Section: Discussionsupporting

confidence: 89%

Safety of Percutaneous Patent Ductus Arteriosus Closure: An Unselected Multicenter Population Experience

El‐Said

Bratincsák

Foerster

et al. 2013

JAHA

View full text Add to dashboard Cite

BackgroundThe technique and safety of transcatheter patent ductus arteriosus (PDA) closure have evolved during the past 20 years. We sought to report a multicenter experience of PDA closure with a focus on the rate of adverse events (AE) and a review of institutional practice differences.Methods and ResultsOutcome data on transcatheter PDA closure were collected at 8 centers prospectively using a multicenter registry (Congenital Cardiac Catheterization Project on Outcome Registry). Between February 2007 and June 2010, 496 PDA closures were recorded using a device in 338 (68%) or coils in 158 (32%). Most patients had an isolated PDA (90%). Fifty percent of patients were between 6 months and 3 years old, with only 40 patients (8%) <6 months old. Median minimum PDA diameter was 2.5 mm (range 1 to 12 mm; IQR 2 to 3 mm) for device closure and 1 mm (range 0.5 to 6 mm; IQR 1 to 2 mm) for coil closure (P<0.001). A device rather than coil was used in patients <3 years, weight <11 kg, and with a PDA minimum diameter >2 mm (all P<0.001). Three of 8 centers exclusively used a device for PDAs with a diameter >1.5 mm. In 9% of cases (n=46), an AE occurred; however, only 11 (2%) were classified as high severity. Younger age was associated with a higher AE rate. Coil‐related AEs were more common than device‐related AEs (10% versus 2%, P<0.001).ConclusionsPDA closure in the present era has a very low rate of complications, although these are higher in younger children. Technical intervention‐related events were more common in coil procedures compared with device procedures. For PDAs ≤2.5 mm in diameter, institutional differences in preference for device versus coil exist.

show abstract

Section: Discussionsupporting

confidence: 89%

Safety of Percutaneous Patent Ductus Arteriosus Closure: An Unselected Multicenter Population Experience

El‐Said

Bratincsák

Foerster

et al. 2013

JAHA

View full text Add to dashboard Cite

show abstract

“…This experience demonstrates that the AVPII is an effective and safe device to be used for PDA closure. The closure rate was as higher or better as reported for the regular ADO device and this has also been reported by others using the AVPII . In our own experience, the closure was routinely demonstrated before the patients leave the catheterization laboratory.…”

Section: Discussionsupporting

confidence: 84%

“…Since the first report of transcatheter PDA closure by Porstmann et al there have been huge improvements in this procedure, mainly due to the development of more simple, safe, and effective devices. This has lead operators to attempt closure of larger PDAs in smaller patients …”

Section: Introductionmentioning

confidence: 99%

Use of the Amplatzer Vascular Plug II Device to Occlude Different Types of Patent Ductus Arteriosus in Pediatric Patients

Garay

Aguirre

Rey

et al. 2015

J Interven Cardiology

View full text Add to dashboard Cite

show abstract

“…Completely successful closure of PDA was achieved in 98% of the patients19). This confirms the safety of transcatheter closure of PDA in children weighing less than 10 kg.…”

Section: Discussionsupporting

confidence: 73%

Clinical outcome of transcatheter closure of patent ductus arteriosus in small children weighing 10 kg or less

et al. 2010

View full text Add to dashboard Cite

PurposeTranscatheter closure has become an effective therapy in most patients with patent ductus arteriosus (PDA). However, there are difficulties in transcatheter closure of PDA in small children. We reviewed clinical outcomes of transcatheter closure of PDA in children weighing less than 10 kg in a single center.MethodsBetween January 2003 and December 2009, 314 patients with PDA underwent transcatheter closure in our institute. Among them, 115 weighed less than 10 kg. All of these patients underwent transcatheter closure of PDA using either COOK Detachable Coil®, PFM Nit-Occlud®, or Amplatzer duct occluder®. A retrospective review of the treatment results and complications was performed.ResultsThe mean age of patients was 9.1±5.9 months (median, 8 months), and mean weight was 7.6±1.8 kg (median, 7.8 kg). The mean diameter of PDA was 3.2±1.4 mm (median, 3 mm). Complete occlusion occurred in 113 patients (98%). One patient was sent to surgery because of a failed attempt at device closure, and another patient had a small residual shunt after device placement. The average mean length of hospital stay was 3.0±3.3 days, and mean follow-up duration was 21.0±19.6 months. There were no major complications in any of the patients.ConclusionTranscatheter closure of PDA is considered safe and efficacious in infants weighing less than 10 kg. With sufficient experience and further effort, transcatheter closure of PDA can be accepted as the gold standard of treatment for this group of patients.

show abstract

Transcatheter Closure of Moderate-to-Large Patent Ductus Arteriosus in Infants Using Amplatzer Duct Occluder

Cited by 40 publications

References 30 publications

Safety of Percutaneous Patent Ductus Arteriosus Closure: An Unselected Multicenter Population Experience

Safety of Percutaneous Patent Ductus Arteriosus Closure: An Unselected Multicenter Population Experience

Use of the Amplatzer Vascular Plug II Device to Occlude Different Types of Patent Ductus Arteriosus in Pediatric Patients

Clinical outcome of transcatheter closure of patent ductus arteriosus in small children weighing 10 kg or less

Contact Info

Product

Resources

About